As the world leader in bioprinting solutions, EnvisionTEC continues to develop bioprinting materials with its global partners as the field of regenerative medicine evolves and bioprinting expands in the coming years into clinical trials and manufacturing production.
More information about the company’s new biomaterials can be found at EnvisionTEC.com/biomaterials.
EnvisionTEC is a leading global provider of professional-grade 3D printing solutions. Founded in 2002 with its pioneering commercial DLP printing technology, EnvisionTEC now sells 3D printers based on six distinct technologies that build objects from digital design files. The company’s technology serves a variety of medical, professional and industrial markets, and is valued for precision, surface quality, functionality and speed. EnvisionTEC’s intellectual property includes more than 140 pending and granted patents. Learn more at EnvisionTEC.com.
Sarah A. Webster, +1-313-888-4460